NEW YORK--(BUSINESS WIRE)--Seaport Global Securities LLC (“Seaport Global”), a full-service investment bank, today announced that Corey Davis, Ph.D. has joined the firm as a Managing Director and Senior Equity Analyst in its New York office. Corey has over 20 years of experience covering biotechnology and specialty pharmaceutical companies with a special focus on central nervous system (CNS) related disorders, including Alzheimer’s disease, bipolar disorder, depression, schizophrenia, epilepsy, multiple sclerosis, and all forms of pain, as well as dermatology, gastroenterology, ophthalmology, and pulmonology.
Previously, Corey was Managing Director in Equity Research at H.C. Wainwright. Prior to that, he spent two years at Canaccord Genuity, four years at Jefferies and three years at Natixis Bleichroeder. He began his career in 1997 at Hambrecht & Quist and remained for nine years as the firm became JP Morgan through acquisitions. He received a BA in Biology from Middlebury College and a Ph.D. in Molecular Biology from Princeton University.
Ed Lainfiesta, Partner of Seaport Global, said, “We are excited to expand our research team with high-caliber talent that Corey brings to Seaport Global. He is well known in the investment community and we are confident he will be instrumental in identifying significant opportunities and bringing fresh ideas to our clients.”
Corey joins Vernon Bernardino, Managing Director and Senior Equity Analyst, whose primary focus is the treatment of cancer, infectious diseases, liver diseases, and cell-based therapies targeting inflammatory disorders and vascular diseases.
About Seaport Global Securities
Seaport Global Securities LLC (www.seaportglobal.com) is a full-service investment bank that offers investment banking, capital markets, financial advisory, sales, trading and research services.
Co-headquartered in New York and New Orleans with offices across the US and in Europe, Seaport Global pairs its extensive knowledge and relationships in the energy, industrials, mining and metals, chemicals, shipping and healthcare industries, with a large platform of equity and fixed income sales, trading and research. The firm’s forward-thinking practitioners, backed by decades of experience, focus on meeting clients’ goals in all business and economic cycles.